Xeureka Inc. uses the latest computational technology, including cutting-edge AI and simulations, to improve the efficiency and success rate of drug discovery research. We aim to contribute to the swift, economical delivery of effective medicines to patients suffering from disease. Xeureka provides solutions for drug discovery research in the areas of both Dry (computational) and Wet (experimental) drug discovery. In addition to analysis and screening services, we plan to sell software and provide SaaS in the future. Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
| Website | https://xeureka.co.jp/ |
| Employees | 9 (7 on RocketReach) |
| Founded | 2021 |
| Industry | Information Services |
| Keywords | Drug Discovery, Ai Drug Discovery, Computational Drug Discovery, Pharmaceutical Research, Biotechnology, Drug Development, Pharmaceutical Ai, In Silico Drug Design, Molecular Modeling, Machine Learning, Deep Learning, Precision Medicine, Drug Design, Computational Biology, Cheminformatics, Bioinformatics, Pharmaceutical Technology, Drug Target Identification, Medical Technology |
| Competitors | OpenAI, IBM, AI Community, Microsoft, NVIDIA, Amazon, DataRobot, C3 AI, Salesforce, H2O.ai +45 more (view full list) |
Looking for a particular Xeureka employee's phone or email?
Xeureka Questions
Taisei Nagae is the President and CEO of Xeureka.
7 people are employed at Xeureka.
Top Xeureka Employees
-
22
-
Satoshi Ono
Science Fellow at Xeureka
Tokyo, JP1 -
誠健 徳良
Director, Product Engineering Manager at Xeureka
Saitama Prefecture, Japan2
